A number of pharmaceutical groups have come out in favor of the Federal Trade Commission’s decision to launch an inquiry into the business practices of the nation’s six largest pharmacy benefit managers, in order to scrutinize their impact on the access and affordability of prescription drugs.
In the next three years the country plans to be “best in the world” at using IT to boost health outcomes, according to Maria Hassel of the Swedish eHealth.
The Federal Trade Commission is requiring the six largest pharmacy benefit managers to provide information and records regarding their business practices. The agency is launching an inquiry into what it called the prescription drug middleman industry to scrutinize the impa
Health insurer Anthem, which will switch its branding to Elevance Health on June 28, has partnered with Happify Health to digitally address the physical and mental health of women. Anthem framed the move as a means of supporting women through their maternal health journey through solutions such as ongoing education, case management and care coordination. […]
The U.S. Department of Health and Human Services, through the Health Resources and Services Administration, is investing close to $15 million in 29 organizations in rural communities to address psychostimulant misuse and related overdose deaths.